January 2015
Transactions of the American Clinical & Climatological Associati;2015, Vol. 126, p87
Academic Journal
Monoclonal antibodies (mAbs) are highly effective anti-cancer agents; however, there is still considerable room for improving their therapeutic impact. Understanding the mechanisms of action of anti-cancer mAbs, and modifying mAb structure based on this understanding, is leading to the design and testing of more effective mAbs.


Related Articles

  • Immunotherapy made more accessible? Secko, David // CMAJ: Canadian Medical Association Journal;7/19/2005, Vol. 173 Issue 2, p144 

    Analyzes a study which demonstrated that it is possible to transfer genes that encode for monoclonal antibody into an animal, allowing the expression of a biologically active monoclonal antibody in vivo. Uses of antibodies; Alternative strategy to manufacturing monoclonal antibodies; Method for...

  • monoclonal antibody.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1486 

    An encyclopedia entry for "monoclonal antibody," which refers to the antibody which is specific to a certain antigen, is presented.

  • Cloning and Sequencing of the VH and YK Genes of an Anti-CD3 Monoclonal Antibody, and Construction of a Mouse/Human Chimeric Antibody1. Arakawa, Fumiko; Kuroki, Masahide; Kuwahara, Motohisa; Senba, Tarumi; Ozaki, Hiroaki; Matsuoka, Yuji; Misumi, Yoshio; Kanda, Hidetoshi; Watanabe, Takeshi // Journal of Biochemistry;1996, Vol. 120 Issue 3, p657 

    Mouse monoclonal antibodies against CD3 on human T lymphocytes have been used for therapy in organ-transplant patients as a potent immunosuppressive agent or for treatment of cancer as a potent T cell activating agent. However, an inherent problem in their in vivo application is the human...

  • A Monoclonal Antibody, 3A10, Recognizes a Specific Amino Acid Sequence Present on a Series of Developmentally Expressed Brain Proteins. Harada, Ayako; Takeuchi, Ken-ichi; Dohmae, Naoshi; Takio, Koji; Uenaka, Toshimitu; Aoki, Junken; Inoue, Keizo; Umeda, Masato // Journal of Biochemistry;1999, Vol. 125 Issue 3, p443 

    Immunoblotting showed that a monoclonal antibody, 3A10, binds to a series of rat brain-specific antigens with molecular masses of 150-,120-,118-,106-,104-,79-, and 77-kDa. The expression of 3A10 antigens is dependent on the developmental stage of the brain; only the 106-kDa antigen is detected...

  • Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component. Parseghian, M.; Mechetner, E.; Osidak, M.; Domogatskii, S. // Russian Journal of General Chemistry;Feb2014, Vol. 84 Issue 2, p345 

    Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable insoluble antigens available for binding with...

  • Identification, frequency, activation and function of CD4+ CD25FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis. Stelmaszczyk-Emmel, Anna; Jackowska, Teresa; Rutkowska-Sak, Lidia; Marusak-Banacka, Maria; Wąsik, Maria // Rheumatology International;May2012, Vol. 32 Issue 5, p1147 

    The aim of the study was to test the frequency of CD4+ CD25FoxP3 regulatory T cells in JIA patients and to assess their activation status and functional activity. The study involved 12 children with JIA and 35 healthy control subjects. PBMC were stained with monoclonal antibodies (anti-CD25,...

  • Methionine Aminopeptidase II: A Molecular Chaperone for Sarcoplasmic Reticulum Calcium ATPase. Noguchi, Shunsuke; Komiya, Tohru; Eguchi, Hiroshi; Shirahata, Akira; Nikawa, Jun-ichi; Kawamura, Masaru // Journal of Membrane Biology;Feb2007, Vol. 215 Issue 2/3, p105 

    The monoclonal antibody to the β-subunit of H+/K+-ATPase (mAbHKβ) cross-reacts with a protein that acts as a molecular chaperone for the structural maturation of sarcoplasmic reticulum (SR) Ca2+-ATPase. We partially purified a mAbHKβ-reactive 65-kDa protein from Xenopus ovary. After...

  • CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Takeshita, A.; Yamakage, N.; Shinjo, K.; Ono, T.; Hirano, I.; Nakamura, S.; Shigeno, K.; Tobita, T.; Maekawa, M.; Kiyoi, H.; Naoe, T.; Ohnishi, K.; Sugimoto, Y.; Ohno, R. // Leukemia (08876924);Jul2009, Vol. 23 Issue 7, p1329 

    We studied the effect of CMC-544, the calicheamicin-conjugated anti-CD22 monoclonal antibody, used alone and in combination with rituximab, analyzing the quantitative alteration of target molecules, that is, CD20, CD22, CD55 and CD59, in Daudi and Raji cells as well as in cells obtained from...

  • Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. Laura Kus; Ewa Borys; Ya Ping Chu; Shawn M. Ferguson; Randy D. Blakely; Marina E. Emborg; Jeffrey H. Kordower; Allan I. Levey; Elliott J. Mufson // Journal of Comparative Neurology;8/25/2003, Vol. 463 Issue 3, p341 

    A mouse monoclonal antibody (clone 62-2E8) raised against a human recombinant high-affinity choline transporter (CHT)-glutathione-S-transferase fusion protein was used to determine the distribution of immunoreactive profiles containing this protein in the monkey central nervous system (CNS)....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics